CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds. Kadry MO, Abdel-Megeed RM. PLoS One 2024;19:e0302264.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kadry MO, Abdel-Megeed RM. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds. PLoS One 2024;19:e0302264.
PMID: 38723038